Status:
COMPLETED
Progression of Hematopoietic Diseases in Shanghai, China
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Fudan University
University of Cincinnati
Conditions:
Hematologic Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristic...
Detailed Description
The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristic...
Eligibility Criteria
Inclusion
- Men and women 18 years or older Diagnosis of hematologic abnormality
Exclusion
- Children Non hematologic diseases
Key Trial Info
Start Date :
August 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
10757 Patients enrolled
Trial Details
Trial ID
NCT00365014
Start Date
August 1 2003
End Date
December 1 2009
Last Update
July 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Joint Sino-US Clinical and Molecular Laboratory (JCML)
Shanghai, China, 200032